￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Talazoparib/talazopanib will be included in medical insurance in 2025

2026-02-01 22:25:32

Check Details
Originating countries and manufacturers of crizotinib

2026-02-01 22:25:32

Check Details
What information does the package insert of Serputinib/Serpatinib capsules contain?

2026-02-01 22:25:32

Check Details
Analysis of the main functions and common side effects of ensidipine

2026-02-01 22:25:32

Check Details
What is the specific treatment effect of avatrombopag/sucoxin?

2026-02-01 22:25:32

Check Details
Monthly Dosage and Treatment Guidelines for Talazoparib/talazopanib

2026-02-01 22:25:32

Check Details
Crizotinib 2025 medical insurance reimbursement policy

2026-02-01 22:25:32

Check Details
Serputinib/serpatinib belongs to the first generation of targeted drugs

2026-02-01 22:25:32

Check Details
Is the generic drug of ensidipine as effective as the original drug?

2026-02-01 22:25:32

Check Details
Common side effects of avatrombopag maleate/Sucoxin

2026-02-01 22:25:32

Check Details
The latest price of a box of Pralsetinib, a targeted drug, and its influencing factors

2026-02-01 22:25:32

Check Details
Capmatinib (Touradida) belongs to which generation of targeted drugs and analysis of its clinical advantages

2026-02-01 22:25:32

Check Details
Category
相关知识